Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Naltrexone injectable sustained release formulation

Naltrexone injectable sustained release formulation

US Patent 12201630 · Granted Jan 21, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ketamine pamoate and use thereof2024
Ketamine pamoate and use thereof2024
Long-acting injectable formulations and crystalline forms of buprenorphine deriv2022
Long-acting injectable formulations and crystalline forms of buprenorphine deriv2022
Sustained-release buprenorphine formulations2020
Sustained-release buprenorphine formulations2020
Formulations of an LSD1 inhibitor2019
Compositions and methods for increasing telomerase activity2018
Compositions and methods for increasing telomerase activity2016
Compositions and methods for increasing telomerase activity2013